Healthpeak Properties (NYSE:DOC) Given New $19.00 Price Target at Evercore ISI

Healthpeak Properties (NYSE:DOC) had its target price decreased by equities researchers at Evercore ISI from $21.00 to $19.00 in a research note issued to investors on Wednesday,Benzinga reports. The firm currently has an “outperform” rating on the real estate investment trust’s stock. Evercore ISI’s price target indicates a potential upside of 16.09% from the stock’s previous close.

DOC has been the subject of a number of other research reports. Cantor Fitzgerald set a $17.00 target price on Healthpeak Properties in a report on Monday, January 5th. Jefferies Financial Group cut Healthpeak Properties from a “buy” rating to a “hold” rating and lowered their target price for the stock from $21.00 to $17.00 in a report on Monday, December 15th. Wells Fargo & Company reissued a “positive” rating on shares of Healthpeak Properties in a research note on Tuesday. The Goldman Sachs Group began coverage on shares of Healthpeak Properties in a report on Friday, January 9th. They issued a “neutral” rating and a $17.00 price objective for the company. Finally, Weiss Ratings upgraded shares of Healthpeak Properties from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Monday, January 26th. Seven analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $19.42.

Healthpeak Properties Price Performance

DOC traded down $0.08 during trading on Wednesday, reaching $16.37. 603,093 shares of the company traded hands, compared to its average volume of 9,796,443. The company has a debt-to-equity ratio of 1.11, a quick ratio of 1.22 and a current ratio of 1.22. The company has a market cap of $11.37 billion, a P/E ratio of 164.07, a PEG ratio of 4.26 and a beta of 1.12. The firm has a fifty day simple moving average of $16.95 and a 200 day simple moving average of $17.62. Healthpeak Properties has a 12-month low of $15.71 and a 12-month high of $21.28.

Healthpeak Properties (NYSE:DOC) last released its earnings results on Monday, February 2nd. The real estate investment trust reported $0.47 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.45 by $0.02. Healthpeak Properties had a net margin of 2.52% and a return on equity of 0.83%. The firm had revenue of $719.40 million during the quarter, compared to analyst estimates of $685.14 million. During the same quarter last year, the business earned $0.46 EPS. The business’s revenue was up 3.1% on a year-over-year basis. Healthpeak Properties has set its FY 2026 guidance at 1.700-1.740 EPS. On average, equities analysts forecast that Healthpeak Properties will post 1.86 EPS for the current year.

Institutional Investors Weigh In On Healthpeak Properties

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Mather Group LLC. acquired a new stake in shares of Healthpeak Properties during the 3rd quarter valued at approximately $25,000. City Holding Co. bought a new position in shares of Healthpeak Properties in the third quarter valued at $26,000. Sound Income Strategies LLC acquired a new position in shares of Healthpeak Properties in the third quarter worth about $28,000. Rexford Capital Inc. acquired a new position in Healthpeak Properties during the second quarter valued at $28,000. Finally, WPG Advisers LLC grew its holdings in shares of Healthpeak Properties by 270.2% during the 4th quarter. WPG Advisers LLC now owns 1,640 shares of the real estate investment trust’s stock valued at $26,000 after acquiring an additional 1,197 shares in the last quarter. Hedge funds and other institutional investors own 93.57% of the company’s stock.

About Healthpeak Properties

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.